Believers Worship Centre founder, Prophet Stephen Adom Kyei-Duah, popularly known as Prophet Adom Kyei-Duah, has come under fresh scrutiny after a senior official of the Food and Drugs Authority (FDA), Dr. Martin Kusi, stated that the popular sobolo drink associated with the preacher has not been approved as a medicinal product.

Speaking in an interview, Dr. Kusi stressed that Ghana’s regulatory framework does not permit any food or beverage to be marketed as having therapeutic or healing benefits unless it has undergone scientific assessment and received approval from the FDA.

Referring to the sobolo drink linked to the preacher, he maintained that it does not qualify for registration as a medicine.

“There is no basis for such a sobolo to be approved as a medicinal product. The FDA won’t approve such a product,” he said.

He explained that while manufacturers are free to sell beverages as food products, the situation changes once claims are made that the product can cure or treat diseases.

“If anyone produces a food or drink and presents it as a drug or as having medicinal properties, he or she has to come to us at the FDA for approval. Otherwise, that is an illegality, and we would have to take action,” he explained.

Dr. Kusi further clarified that the FDA’s responsibility is limited to evaluating scientific evidence behind health claims and not matters of faith or spirituality.

“The FDA doesn’t deal in spirituality. If someone sells a drink and says it can deliver miracles, that is not our problem. But if the drink is said to heal certain ailments, then it is not just a normal drink. It has to first be brought to the FDA for evaluation. Otherwise, it is a criminal act, and we would have to take it up,” he clarified.

The comments come amid ongoing public discussions surrounding products associated with Prophet Adom Kyei-Duah, particularly claims that some of them possess healing properties. Under Ghana’s public health regulations, any product advertised with medicinal claims must first receive approval from the FDA before it can legally be promoted for such purposes. Dr. Kusi’s remarks reinforce the authority’s position that health claims must be supported by scientific evidence and regulatory clearance, regardless of the source or promoter.

Watch the interview below:

Source: Yvonne Nyarko Agyemang